BRAF V600E Genotyping Reagents
Platform - Taqman Probe-based qualitative reagent set for Real-Time PCR system.
Unit - Per sample
This test uses DNA extracted from the peripheral blood to evaluate for the presence of BRAF V600E and V600K alterations. A positive result indicates the presence of an activating BRAF alteration and may be useful for guiding the treatment of individuals with melanoma.
Min Requirement -25 Reactions